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BACKGROUND: Posttraumatic stress disorder (PTSD) is a frequent anxiety disorder with higher prevalence rates in
female patients than in male patients (2.5:1). Association with a single nucleotide polymorphism (rs2267735) in the
gene ADCYAP1R1 encoding the type I receptor (PAC1-R) of the pituitary adenylate cyclase activating polypeptide
has been reported with PTSD in female patients. We sought to identify the neural correlates of the described PAC1-R
effects on associative learning.
METHODS: In a reverse genetic approach, we examined two independent healthy samples (N1 5 112, N2 5 73)
using functional magnetic resonance imaging during cued and contextual fear conditioning. Skin conductance
responses and verbal self-reports of arousal, valence, and contingency were recorded.
RESULTS: We found that PAC1-R modulates the blood oxygenation level–dependent response of the hippo-
campus. Speciﬁcally, we observed decreased hippocampal activity during contextual, but not during cued, fear
conditioning in female participants carrying the PAC1-R risk allele. We observed no signiﬁcant differences in
conditionability for skin conductance responses, verbal reports, or activation in other brain regions between the
genotype groups in female participants.
CONCLUSIONS: Our results suggest that impaired contextual conditioning in the hippocampal formation may
mediate the association between PAC1-R and PTSD symptoms. Our ﬁndings potentially identify a missing link
between the involvement of PAC1-R in PTSD and the well-established structural and functional hippocampal deﬁcits
in these patients.
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Biohttp://dx.doi.org/10.1016/j.biopsych.2014.12.018Learning to cope with environmental stressors is a highly
adaptive process. However, this process can become malad-
aptive, such as in patients with anxiety disorders such as
posttraumatic stress disorder (PTSD). Women have a higher
prevalence than men for many anxiety disorders (female-to-male
ratio for PTSD 5 2.5:1) (1). Why only some individuals (and
women to a higher degree) develop anxiety symptoms after a
traumatic experience, whereas others readjust is poorly under-
stood. Interindividual differences, such as prior learning history or
genetic background, likely inﬂuence the ability to deal with
stressful experiences. Heredity has a partial role in the develop-
ment of PTSD (38%–41%) (2), and several genes have been
found to be associated with this disorder (3). A single nucleotide
polymorphism (rs2267735) in the type I receptor (PAC1-R) of the
pituitary adenylate cyclase activating polypeptide (PACAP) was
found to be predictive of PTSD symptoms in female patients, but
not male patients. It could also be associated with impaired fear
discrimination in healthy female, but not male, participants (4).0 & 2015 Society of Biological Psychiatry
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SEE COMMENTAPACAP exerts pleiotropic functions in the body. Most
importantly, it has been found to regulate neuroendocrine
stress circuits (5) and has been implicated in associative
learning processes such as context conditioning (6,7) that
have also been implicated in PTSD (8). The reported sex-
speciﬁc effects may occur via the regulation of the PAC1-R
encoding gene ADCYAP1R1 by estrogen (4). Compatible with
its role in coping with stress and learning, PAC1-R is
predominantly expressed in brain structures such as the
neocortex or the limbic system. The hippocampus is one of
the limbic structures with the highest PAC1-R concentrations
(9), and dysfunction in the hippocampus has been related
to PTSD (10). The hippocampus also inﬂuences the bodily
stress response (11) and is involved in associative learning,
speciﬁcally in contextual conditioning (12). Impairments in
hippocampus-dependent contextual fear conditioning have
been shown in PAC1-R-deﬁcient mice (7,13). Most probably
PAC1-R modulates associative hippocampal learning throughrnal ISSN: 0006-3223
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Psychiatryits involvement in a form of long-term potentiation of mossy
ﬁber-CA3 synapses (13). Later experiments additionally impli-
cated PAC1-R in anxiety-like behavior in rats and mice and in
healthy humans using cued fear conditioning paradigms (4).
Women, but not men, with higher PACAP blood levels showed
higher overall acoustic startle reﬂexes and impaired discrim-
ination of cues signaling safety or danger during the acquis-
ition of cued fear conditioning, which is in line with ﬁndings in
patients with PTSD (14) and could additionally be replicated in
healthy female participants carrying the PAC1-R risk allele (4).
For mice, increased PACAP and PAC1-R messenger RNA
(mRNA) expression was reported in the amygdala during
consolidation, which reﬂects acute fear responses and is
assumed to model PTSD (15). Similar to the hippocampus,
the amygdala is one of the limbic structures with high PAC1-R
concentrations (9), which is involved in the regulation of the
bodily stress response (11), is essential for associative learning
(i.e., cued and contextual fear conditioning) (16) and is related
functionally as well as structurally to PTSD (10,17).
In the present study, we tested the hypothesis that PAC1-R
inﬂuences learning relevant for PTSD. We employed an
imaging genetics approach using contextual and cued fear
conditioning (heritability 35%–45% (18)) in healthy volun-
teers. During fear conditioning, an originally neutral stimulus
or context is presented several times together with an
unconditioned threat stimulus (US) and subsequently
becomes a conditioned stimulus (CS) or context (CXT),
which elicits conditioned fear or anxiety responses (CR).
Conditioned cues evoke phasic fear responses, whereas
contexts lead to sustained anxiety responses (19). Patients
with PTSD show contextual deﬁcits (20), which also repre-
sents a vulnerability factor for the development of anxiety
disorders such as PTSD (21). During cued fear conditioning,
heightened physiologic reactions were observed in patients
with PTSD (14).
If dysfunctional fear conditioning is relevant for PTSD,
patients with PTSD should show alterations in the brain circuits
involved in contextual and cued fear conditioning, and these
changes should be apparent in risk allele carriers. Both patients
with PTSD and PAC1-R-deﬁcient mice show impairments in
hippocampus-dependent contextual fear conditioning (7,8,13),
with reduced and potentially compensatory enhanced activa-
tion. We expected to see altered activity in the hippocampus in
female risk allele carriers during contextual fear conditioning in
an additive model. For cued fear conditioning, we expected
heightened amygdalar activation in female risk allele carriers,
given the described animal research showing increased PACAP
and PAC1-R mRNA expression in the amygdala, which reﬂects
acute fear responses and is assumed to model PTSD (15). In
addition, amygdalar activation in cued fear conditioning has
been shown to be enhanced in PTSD (22). We were interested
in the effect of PACAP on brain activations in male participants,
which we tested in an explorative manner.
METHODS AND MATERIALS
Participants
The initial study comprised 112 participants (39 female) of
Caucasian descent (discovery sample). The volunteers wereBiological Psychrecruited from training schools for rescue workers (who have
a heightened risk to experience traumatic events) in the course
of a longitudinal study on predictors of PTSD. Imaging data
from the entire sample have already been published with a
focus on genetic polymorphisms for alcoholism (cue condition-
ing (23)) and for schizophrenia (context conditioning (24)). The
second study cohort of 72 participants (24 female) took part in
the same longitudinal study as a second wave (replication
sample). Participants with a mental disorder, as determined by
the German version of the Structured Clinical Interview for
DSM-IV (25), were excluded from the study. Sample character-
istics are presented in Table S1 in Supplement 1.
The study was approved by the Ethics Committee of the
Medical Faculty Mannheim of Heidelberg University, and written
informed consent was obtained before participation. The study
conformed to the Code of Ethics of the World Medical
Association (Declaration of Helsinki, sixth revision, 2008).
DNA Extraction and Genotyping
Based on standard procedures, genomic DNA was prepared
from whole blood. Using a TaqMan 50 nuclease assay,
rs12807809 was genotyped. By duplicating 15% of the
original sample, we assessed accuracy, and reproducibility
was 100%. The allele frequencies for the female discovery
sample (GG, n 5 15; GC, n 5 18; CC, n 5 6) and for the male
sample (GG, n 5 19; GC, n 5 38; CC, n 5 16) did not deviate
from Hardy-Weinberg equilibrium (pfemale 5 1.0 and pmale 5
1.0). The same was true for the entire sample (pall 5 1.0). The
allele frequencies for the replication sample (female partic-
ipants, GG, n 5 9; GC, n 5 8; CC, n 5 7; male participants,
GG, n 5 17; GC, n 5 24; CC, n 5 7) did not deviate from
Hardy-Weinberg equilibrium (pfemale 5 .11 and pmale 5 1.0).
The same applied to the entire sample (pall 5 .47).
Neuropsychological and Clinical Assessment
Neuropsychological assessments were conducted to ensure
comparability between the groups. We screened intelligence
using the German version of the Culture Fair Intelligence Test
(26). Memory performance was assessed by the California
Verbal Learning Test (27). To control for trait anxiety as a
potential confounder of conditioning, we used the trait version
of the State–Trait Anxiety Inventory (28).
Experimental Procedure
Unconditioned Threat Stimulus. An electrical stimulus
served as US and was delivered by a copper electrode
to the right thumb, using an electrical stimulus generator
(DS7A; Digitimer Ltd, Welwyn Garden City, United Kingdom).
We administered increasingly intense stimuli (50-ms bursts,
12 Hz) starting with a mild stimulus until each participant
indicated it as “painful” (pain threshold) and then further until
the pain became unbearable (pain tolerance). After threefold
repetition, we averaged values of the last two trials. Next, each
volunteer received a painful stimulus, starting at 80% between
the threshold and the tolerance level, which had to be rated
with respect to the intensity and unpleasantness on two Likert
scales ranging from 0 (not painful or unpleasant) to 10
(extremely painful or unpleasant). The stimulation intensityiatry December 15, 2015; 78:840–847 www.sobp.org/journal 841
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unpleasantness scale reached a level of 7.
To guarantee the safety of participants, all were extensively
informed beforehand and monitored constantly during the
entire pain procedure (quick abortion was possible at all times
without any negative consequences). Also, the stimulus gen-
erator has a special certiﬁcation within the boundaries of the
law for medical products for medical use with very high safety
standards. The procedure has been used in earlier work from
our laboratory (12,23,24).
Contextual Fear Conditioning. As described earlier (24),
contextual fear conditioning comprised four phases: habitu-
ation, early acquisition, late acquisition, and extinction. In line
with previous studies, two different spatial contexts (CXT1
/CXT2) were represented using two colors (orange and blue),
which “surrounded” the subject by illuminating the entire
scanner (Figure S1 in Supplement 1). To enhance a complex
processing of the employed stimuli and to reinforce the feeling
of context, the colors were slowly blended in. After having
reached their full spectrum (for 3–12 seconds), the respective
contextual color stimulus changed into the next color. The
CXT1/CXT2 succession was randomly assigned (but identical
for each subject), and the colors serving as CXT1 were
counterbalanced across volunteers. Using a mirror system to
project the stimuli into the magnetic resonance tomograph, a
surround color (i.e., an actual context) was realized.
During each context conditioning phase, CTX1 and CTX2 were
displayed (3–12 seconds) 10 times in random order. The US
(2.9 seconds) occurred during the habituation phase 10 times in the
interstimulus interval (4–12 seconds); during acquisition, the US
was coupled to half of the CTX1 (50% reinforcement rate). To
maximize unpredictability, US onset was randomly assigned over
the time course of the CXT1 (3–8 seconds after CS1 onset), which
produces greater context conditioning (29,30). CTX2 was never
accompanied by the US (safe condition). During extinction, no US
was presented. The participants were told to view the stimuli
passively and were uninformed about the CXT-US contingency.
Cued Fear Conditioning. The study participants took part
in contextual and cued fear conditioning in counterbalanced
order with structural brain measurements interspersed. As for
contextual fear conditioning, the protocol consisted of habit-
uation, early acquisition, late acquisition, and extinction. In
contrast, two colored geometric shapes (square and diamond)
were used as CS1/CS2, which had a clear onset and offset.
Colors were counterbalanced across participants, and the
CS1/CS2 sequence was pseudorandomized.
During habituation, 10 CS1 and CS2 were presented for
6 seconds, and 4 US (during the interstimulus interval, 7–12
seconds) were presented for 2.9 seconds. The acquisition and
extinction phases comprised 18 presentations of each CS. During
acquisition, the US was coupled to 50% of the CS1 (starting 3.1
seconds after cue onset). Stimuli were projected on a screen in
the scanner room visible to the participants via a mirror system.
Data Acquisition and Analysis
Skin conductance response (SCR) data were analyzed accor-
ding to standard procedures as described earlier (24). The842 Biological Psychiatry December 15, 2015; 78:840–847 www.sobpself-report scales, for arousal and emotional valence, were
based on the Self-Assessment Manikin (31). Additionally,
perceived contingency between the CS and US (1 5 no
CS-US contingency to 9 5 perfect CS-US contingency) was
rated after each conditioning phase. Functional scans for the
discovery and replication sample were acquired with 1.5-tesla
and 3-tesla scanners (Siemens AG, Erlangen, Germany),
respectively, using an echo planar imaging sequence and
analyzed with SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm). We
used the general linear model to investigate genotype effects
on the neural response to cue and context conditioning. For
the hippocampus and amygdala, region of interest masks from
the Wake Forest University (Automated Anatomical Labeling
atlas) PickAtlas v3.0.3 (32) were employed. Details on the
methods, analyses, and results are provided in Supplement 1.RESULTS
Neuropsychological and Clinical Assessments and
Magnetic Resonance Imaging Data
Although we counterbalanced the order of the two condition-
ing procedures, we tested for potential differences between
the genotype groups, which yielded nonsigniﬁcant results for
female [χ22 5 1.34, p 5 .51] and male [χ22 5 2.21, p 5 .33]
participants for the entire sample. Separated for the two
studies, we observed in the discovery sample nonsigniﬁcant
results for female [χ22 5 .19, p 5 1.00] and male [χ22 5 .91,
p 5 .63] participants. In the replication sample, a comparable
picture emerged for the female [χ22 5 2.53, p 5 .35] and male
[χ22 5 1.88, p 5 .41] participants.
In the discovery sample, the three genotype groups did not
differ signiﬁcantly with respect to age or sex ratio. Levels of
intelligence (Culture Fair Intelligence Test), trait anxiety (State–
Trait Anxiety Inventory), and hippocampus-dependent memory
(California Verbal Learning Test) were comparable between the
groups (Tables S2 and S3 in Supplement 1). For the general
task-related brain activations during late acquisition of con-
textual fear conditioning, we observed signiﬁcant whole-brain
activations (familywise error corrected, p , .05) for the CXT1
. CXT2 contrast in a network comprising the cerebellum and
parietal, occipital, and frontal lobes (Table S4 in Supplement 1
presents general task-related brain activations during cued
and contextual fear conditioning). We found signiﬁcant hippo-
campal and amygdalar responses in the entire discovery
sample (Figure S2 in Supplement 1).
SCRs and Self-Report Data
Successful fear conditioning was shown by SCRs and verbal
self-reports and did not differ between allele groups
(Supplement 1).
Functional Magnetic Resonance Imaging Results
During Fear Conditioning
During contextual fear conditioning, signiﬁcant hippocampal
and amygdalar activation was present in all participants
(N 5 112, 39 females). Female carriers of the PAC1-R risk
allele for PTSD showed a signiﬁcantly reduced gene-dose–
dependent activation in the left hippocampus during late.org/journal
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did not ﬁnd any signiﬁcant association of PAC1-R with
amygdalar activation during contextual conditioning in female
participants. During early acquisition and extinction, we
observed no signiﬁcant effects of genotype for female partic-
ipants. We replicated the results from the discovery sample.
Female carriers of the PAC1-R risk allele in the replication
sample again showed signiﬁcantly reduced left-sided hippo-
campal activation during late acquisition (t 5 4.92, p , .001)
(Figure 1C,D). Additionally, no other brain region was found to
be signiﬁcantly inﬂuenced by PAC1-R genotype at an explor-
atory threshold (puncorrected , .001) for female participants,
suggesting regional speciﬁcity of our result.
For the male participants, we observed a dose-dependent
effect in the right hippocampus (t 5 3.85, p 5 .036) (Figure 2A,B)
during late acquisition (i.e., male carriers of the PAC1-R risk
allele showed signiﬁcantly increased right-sided hippocampalFigure 1. Relationship between the type I receptor of the pituitary adenylate cy
participants. (A) Discovery study (n 5 39). Signiﬁcant gene-dose effect during lat
of two rs2267735 risk alleles (CC) showing the least hippocampal activation and
x 5 220, y 5 237, z 5 2, k 5 20; t 5 4.06, p 5 .038 is familywise error correcte
puncorrected, .05. (B) Discovery study. Effect sizes (CXT1 . CXT2) in the hippoca
late acquisition (error bars indicate SEM). (C) Replication study (n 5 24). Signiﬁca
CXT2 contrast with carriers of two rs2267735 risk alleles (CC) showing the lea
activation. The peak voxel at x 5 218, y 5 241, z 5 4, k 5 36; t 5 4.92, p , .001
the discovery study. (D) Replication study. Effect sizes (CXT1 . CXT2) in the hip
acquisition (error bars indicate SEM). ROI, region of interest.
Biological Psychactivation). In contrast, we did not ﬁnd any signiﬁcant asso-
ciation of PAC1-R with amygdalar activation during contextual
conditioning in male participants. During early acquisition and
extinction, we observed no signiﬁcant effects of genotype for
male participants. Additionally, no other brain region was
found to be inﬂuenced by PAC1-R genotype at an exploratory
threshold (puncorrected , .001) for male participants, suggesting
regional speciﬁcity of this result. For cued fear conditioning,
we did not observe any signiﬁcant inﬂuence of PAC1-R on
amygdalar or hippocampal activity in male participants. In the
replication analysis with 48 healthy participants of Caucasian
descent (from a second cohort), we found only a trend toward
signiﬁcance in the right hippocampus (t 5 2.54, p 5 .086)
(Figure 2C,D) during late acquisition.
Based on the observed ﬁndings in female and male
participants, we decided also to investigate sex-genotype
interactions in a general model using gender as a covariateclase activating polypeptide (PAC1-R) and hippocampal activation in female
e acquisition of contextual fear for the CXT1 . CXT2 contrast with carriers
GG carriers showing the most hippocampal activation. The peak voxel at
d for the region of interest. Colors indicate t scores, shown at a threshold of
mpus region of interest separately for the three PAC1-R allele groups during
nt gene-dose effect during late acquisition of contextual fear for the CXT1 .
st hippocampal activation and GG carriers showing the most hippocampal
is familywise error corrected for a 6-mm sphere around the peak voxel from
pocampus sphere separately for the three PAC1-R allele groups during late
iatry December 15, 2015; 78:840–847 www.sobp.org/journal 843
Figure 2. Relationship between type I receptor of the pituitary adenylate cyclase activating polypeptide (PAC1-R) and hippocampal activation in male
participants. (A) Discovery study (n 5 72). Signiﬁcant gene-dose effect during late acquisition of contextual fear for the CXT1 . CXT2 contrast with carriers
of two rs2267735 CC alleles showing the highest hippocampal activation and GG carriers showing the lowest hippocampal activation. Signiﬁcantly increased
hippocampal activation during late acquisition of contextual fear in carriers of the rs2267735 risk allele (CC, n 5 16) compared with heterozygotes (CG,
n 5 38) and GG carriers (n 5 19) for the CXT1 . CXT2 contrast. The peak voxel at x 5 34, y 5 27, z 5 226, k 5 15; t 5 3.85, p 5 .036 is familywise error
corrected for the region of interest. Colors indicate t scores, shown at a threshold of puncorrected , .05. (B) Discovery study. Effect sizes (CXT1 . CXT2) in the
hippocampus region of interest separately for the three PAC1-R allele groups during late acquisition (error bars indicate SEM). (C) Replication study (n 5 48).
Gene-dose effect (trend level only) during late acquisition of contextual fear for the CXT1 . CXT2 contrast with carriers of two rs2267735 CC alleles showing
the highest hippocampal activation and GG carriers showing the lowest hippocampal activation. The peak voxel at x 5 30, y 5 24, z 5 223, k 5 5; t 5 2.54,
p 5 .086 is familywise error corrected for a 6-mm sphere around the peak voxel from the discovery study. (D) Replication study. Effect sizes (CXT1 . CXT2)
in the hippocampus sphere separately for the three PAC1-R allele groups during late acquisition (error bars indicate SEM). ROI, region of interest.
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hippocampus or any other brain region (familywise error
corrected p . .94). For cued fear conditioning, no signiﬁcant
inﬂuence of PAC1-R on amygdalar or hippocampal activity in
female or male participants was observed.DISCUSSION
The development of PTSD after a traumatic experience is
thought to depend critically among other factors on the
genetic vulnerability of an individual. In the present study, we
investigated the effect of a known vulnerability gene in
participants without PTSD. Although participants experienced
no trauma, we expected that risk gene carriers would react
differently to nonrisk carriers. Although no effect was seen on
the behavioral level, we found that female carriers of the
PAC1-R risk allele for PTSD showed gene-dose–dependent,844 Biological Psychiatry December 15, 2015; 78:840–847 www.sobpdiminished hippocampal activation during contextual fear
conditioning in both studies, which is well in line with the
previously reported increased PTSD symptoms in female risk
allele carriers (4) and the more recent notion that genetic
variants are more penetrant at the level of brain measures (33).
Additionally, our ﬁndings indicate speciﬁcity of the neural
mechanism mediating the PAC1-R–PTSD association. Despite
modulation of hippocampal activity by the PAC1-R genotype,
we found no evidence for other relevant brain regions, even on
an exploratory threshold.
We explored if PAC1-R genotype would have an impact on
neural activity in male participants. We found the opposite
pattern—risk allele carriers showed gene-dose–dependent,
signiﬁcantly increased hippocampal activity during late con-
textual acquisition. However, this result was reproducible
only on a trend level in the replication sample. The test for
a potential sex-genotype interaction yielded no signiﬁcant.org/journal
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locations in men (right-sided) and women (left-sided). We
conclude that the reported PACAP-PTSD association (4) is
mediated via the hippocampus in women in a dose-dependent
manner, whereas this link could not be found in male patients.
Nevertheless, PAC1-R genotype has an impact on hippo-
campal activation in men, but possibly via a different mech-
anism. Further studies are needed to address this question,
which is beyond the scope of this study.
Although we observed PAC1-R-dependent hippocampal
activation differences in both sexes during late contextual fear
acquisition, we found no signiﬁcant differences during habit-
uation, early acquisition, or extinction. This ﬁnding is well in
line with earlier work from our group on this paradigm, where
the strongest hippocampal activation was observed during
this phase (12). During cued fear conditioning, participants
learn to differentiate CS1/CS2 already during early acquis-
ition (23), most probably owing to the fact that US onset is
unpredictable in a context conditioning paradigm compared
with a cue conditioning paradigm. Our data suggest that
PAC1-R plays a role in the acquisition of fear rather than
extinction learning; this might be related to the observation
that not “pure” hippocampal activations, but hippocampal-
prefrontal interactions, are important for contextual extinction
(34). We found no evidence for an impact of PAC1-R on
prefrontal areas.
In contrast to our hypotheses, we did not observe any
association between PAC1-R and cued fear conditioning in
acquisition or extinction. Although this ﬁnding is not in line
with the data from Ressler et al. (4), it replicates earlier
research showing impairments in contextual fear conditioning
but intact cued fear learning in PAC1-R-deﬁcient mice (13).
Ressler et al. (4) recorded startle responses to the CS1 and
CS2, whereas in the present study (owing to the scanner
environment), only SCRs were used. This methodologic
difference might have contributed to discrepancies in the
results on the relationship of the PAC1-R polymorphism and
cued fear conditioning because acoustic startle responses
could potentially be more sensitive to detect subtle differ-
ences (35). We found only a genetic inﬂuence on hippo-
campal activity, a brain structure not essential for simple cue
conditioning paradigms (16).
Since their initial report in 2011, Ressler et al. replicated (36)
and extended (37) their ﬁndings. Male and female children
carrying the PAC1-R risk allele showed pronounced dark-
enhanced startle responses suggesting genetic vulnerability to
be evident in both sexes during development but only in
women after adolescence because of changes in the estrogen
system. The ﬁrst replication attempts from an independent
laboratory using two large population-based samples were
unsuccessful (38); however, a less traumatized cohort (39) was
used. The authors also studied gene-environment interaction
with the assessment of childhood maltreatment in a large
sample of American women and tested for interaction effects
with the PAC1-R polymorphism to predict past month PTSD
and PTSD severity. They observed a signiﬁcant PAC1-R 3
childhood maltreatment interaction in the hypothesized direc-
tion—that is, women with a history of childhood maltreatment
are at a higher risk to develop PTSD if they are risk allele
carriers (40). These authors also reported a relationshipBiological Psychbetween the risk genotype and increased reactivity of the
amygdala and hippocampus in traumatized African-American
women to fearful versus neutral faces in a functional magnetic
resonance imaging investigation (41). Another independent
study in Chinese earthquake survivors with PTSD observed
higher emotional numbing symptoms in female risk allele
carriers (42). Our results contribute to these ﬁndings by
providing a neural mechanism for the PAC1-R–PTSD associ-
ation in female risk allele carriers with the hippocampus as key
component and by extending the role of the PAC1-R in fear
learning to male subjects as well.
This study has several limitations. Given the small sample
size in the group of female risk allele carriers, one might
question the robustness of the results. However, the repli-
cability of our initial ﬁnding argues in favor of reliable differ-
ences. Still, we cannot rule out the possibility that we might
have detected additional signiﬁcant differences in other brain
regions or on a behavioral level with larger sample sizes.
Although we counterbalanced the order of the cued and
contextual fear conditioning paradigms, one cannot rule out
the possibility of transfer effects from the ﬁrst to second
learning or even interactions of this transfer with variables
such as age or intelligence. A more detailed analysis (trial by
trial) of the limited number of SCRs (63 of N 5 112) was
impossible because of a technical artifact in the scanner
resulting in missing values during acquisition and extinction.
Also, although we were able to replicate our results, the
second cohort was measured in a different scanner (1.5-tesla
vs. 3-tesla), limiting the direct comparability of the two
cohorts. Although we investigated healthy participants with-
out PTSD, this allowed the investigation of a sample uncon-
founded by factors typically present in patients, such as
medication or different disorder subtypes. We did not control
for phase of menstrual cycle or contraceptive medication
in female participants. Future studies should address this
issue, given that estrogen functions as a potential regul-
ator of ADCYAP1R1 (4) and can potentially inﬂuence fear
conditioning (43).
In conclusion, our data revealed that hippocampal activity
during contextual fear conditioning is affected by a sex-
speciﬁc PAC1-R genotype effect. The results might form the
missing link between the reported hippocampal impairments
(e.g., hippocampal hypoactivation in PTSD (10)) and the
previous ﬁnding that female patients with PTSD carrying the
PAC1-R risk allele have higher total symptom scores (4).
Because healthy female risk allele carriers show diminished
hippocampal activation during fear learning, but no signiﬁcant
behavioral effect could be detected, it is assumed that this
difference to noncarriers of the risk allele becomes more
pronounced and behaviorally relevant after traumatic experi-
ences. This assumption would ﬁt the postulated higher
penetrance of genetic variants on brain measures (33) and
behavior differences in female risk allele carriers with PTSD (4).
These ﬁndings contribute to our understanding of the neural
mechanisms behind the association of PAC1-R and PTSD and
sex-speciﬁc differences in PTSD and aversive contextual
associative learning processes in general. Because this was
a healthy sample, we do not know what the observed altered
brain activation patterns in the high-risk groups mean with
respect to clinical populations. Although our results ﬁt the dataiatry December 15, 2015; 78:840–847 www.sobp.org/journal 845
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sample, as suggested by previous studies on ﬁre workers who
were more resilient than the general population (44). Further
research is needed to understand how other individual and
environmental factors inﬂuence PAC1-R functioning and its
relationship to PTSD.
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